Christopher Rovaldi - Apr 1, 2022 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Signature
/s/ Esther Cho, Attorney-in-Fact
Stock symbol
KROS
Transactions as of
Apr 1, 2022
Transactions value $
-$35,851
Form type
4
Date filed
4/5/2022, 04:31 PM
Previous filing
Feb 3, 2022
Next filing
Apr 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Options Exercise $13.8K +864 $16.00 864 Apr 1, 2022 Direct
transaction KROS Common Stock Sale -$109 -2 -0.23% $54.34 862 Apr 1, 2022 Direct F1
transaction KROS Common Stock Sale -$5.84K -104 -12.06% $56.20 758 Apr 1, 2022 Direct F1, F2
transaction KROS Common Stock Sale -$16.3K -287 -37.86% $56.89 471 Apr 1, 2022 Direct F1, F3
transaction KROS Common Stock Sale -$21.2K -366 -77.71% $57.97 105 Apr 1, 2022 Direct F1, F4
transaction KROS Common Stock Sale -$6.18K -105 -100% $58.83 0 Apr 1, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KROS Employee Stock Option (right to buy) Options Exercise $0 -864 -8.16% $0.00 9.73K Apr 1, 2022 Common Stock 864 $16.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.50 to $56.23 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.50 to $57.43 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.58 to $58.26 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.62 to $59.275 inclusive.
F6 One-fourth (1/4th) of the shares subject to the option vested on January 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.